Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
‘Imminent’ Gilenya ANDA Launches Halted By US Supreme Court
Favorable Federal Circuit Ruling Is Overturned By Highest Federal Court
Oct 03 2022
•
By
Dean Rudge
The US Supreme court has stepped in for Novartis • Source: Shutterstock
More from Generics
More from Products
